These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 12191639)
1. The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Klenova EM; Morse HC; Ohlsson R; Lobanenkov VV Semin Cancer Biol; 2002 Oct; 12(5):399-414. PubMed ID: 12191639 [TBL] [Abstract][Full Text] [Related]
2. BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Loukinov DI; Pugacheva E; Vatolin S; Pack SD; Moon H; Chernukhin I; Mannan P; Larsson E; Kanduri C; Vostrov AA; Cui H; Niemitz EL; Rasko JE; Docquier FM; Kistler M; Breen JJ; Zhuang Z; Quitschke WW; Renkawitz R; Klenova EM; Feinberg AP; Ohlsson R; Morse HC; Lobanenkov VV Proc Natl Acad Sci U S A; 2002 May; 99(10):6806-11. PubMed ID: 12011441 [TBL] [Abstract][Full Text] [Related]
3. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Vatolin S; Abdullaev Z; Pack SD; Flanagan PT; Custer M; Loukinov DI; Pugacheva E; Hong JA; Morse H; Schrump DS; Risinger JI; Barrett JC; Lobanenkov VV Cancer Res; 2005 Sep; 65(17):7751-62. PubMed ID: 16140943 [TBL] [Abstract][Full Text] [Related]
4. The structural complexity of the human BORIS gene in gametogenesis and cancer. Pugacheva EM; Suzuki T; Pack SD; Kosaka-Suzuki N; Yoon J; Vostrov AA; Barsov E; Strunnikov AV; Morse HC; Loukinov D; Lobanenkov V PLoS One; 2010 Nov; 5(11):e13872. PubMed ID: 21079786 [TBL] [Abstract][Full Text] [Related]
5. Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors. Renaud S; Pugacheva EM; Delgado MD; Braunschweig R; Abdullaev Z; Loukinov D; Benhattar J; Lobanenkov V Nucleic Acids Res; 2007; 35(21):7372-88. PubMed ID: 17962299 [TBL] [Abstract][Full Text] [Related]
6. Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene. Hoivik EA; Kusonmano K; Halle MK; Berg A; Wik E; Werner HM; Petersen K; Oyan AM; Kalland KH; Krakstad C; Trovik J; Widschwendter M; Salvesen HB Oncotarget; 2014 Feb; 5(4):1052-61. PubMed ID: 24658009 [TBL] [Abstract][Full Text] [Related]
7. The evolution of epigenetic regulators CTCF and BORIS/CTCFL in amniotes. Hore TA; Deakin JE; Marshall Graves JA PLoS Genet; 2008 Aug; 4(8):e1000169. PubMed ID: 18769711 [TBL] [Abstract][Full Text] [Related]
8. Testis-specific transcriptional regulators selectively occupy BORIS-bound CTCF target regions in mouse male germ cells. Rivero-Hinojosa S; Kang S; Lobanenkov VV; Zentner GE Sci Rep; 2017 Feb; 7():41279. PubMed ID: 28145452 [TBL] [Abstract][Full Text] [Related]
9. Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Hong JA; Kang Y; Abdullaev Z; Flanagan PT; Pack SD; Fischette MR; Adnani MT; Loukinov DI; Vatolin S; Risinger JI; Custer M; Chen GA; Zhao M; Nguyen DM; Barrett JC; Lobanenkov VV; Schrump DS Cancer Res; 2005 Sep; 65(17):7763-74. PubMed ID: 16140944 [TBL] [Abstract][Full Text] [Related]
10. BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas. Hines WC; Bazarov AV; Mukhopadhyay R; Yaswen P PLoS One; 2010 Mar; 5(3):e9738. PubMed ID: 20305816 [TBL] [Abstract][Full Text] [Related]
11. Discovering a binary CTCF code with a little help from BORIS. Lobanenkov VV; Zentner GE Nucleus; 2018 Jan; 9(1):33-41. PubMed ID: 29077515 [TBL] [Abstract][Full Text] [Related]
12. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Ohlsson R; Renkawitz R; Lobanenkov V Trends Genet; 2001 Sep; 17(9):520-7. PubMed ID: 11525835 [TBL] [Abstract][Full Text] [Related]
13. The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells. Tiffen JC; Bailey CG; Marshall AD; Metierre C; Feng Y; Wang Q; Watson SL; Holst J; Rasko JE Int J Cancer; 2013 Oct; 133(7):1603-13. PubMed ID: 23553099 [TBL] [Abstract][Full Text] [Related]
14. CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region. Nguyen P; Cui H; Bisht KS; Sun L; Patel K; Lee RS; Kugoh H; Oshimura M; Feinberg AP; Gius D Cancer Res; 2008 Jul; 68(14):5546-51. PubMed ID: 18632606 [TBL] [Abstract][Full Text] [Related]
15. CTCF and BORIS in genome regulation and cancer. Marshall AD; Bailey CG; Rasko JE Curr Opin Genet Dev; 2014 Feb; 24():8-15. PubMed ID: 24657531 [TBL] [Abstract][Full Text] [Related]
16. Comparative analyses of CTCF and BORIS occupancies uncover two distinct classes of CTCF binding genomic regions. Pugacheva EM; Rivero-Hinojosa S; Espinoza CA; Méndez-Catalá CF; Kang S; Suzuki T; Kosaka-Suzuki N; Robinson S; Nagarajan V; Ye Z; Boukaba A; Rasko JE; Strunnikov AV; Loukinov D; Ren B; Lobanenkov VV Genome Biol; 2015 Aug; 16(1):161. PubMed ID: 26268681 [TBL] [Abstract][Full Text] [Related]
18. The combined action of CTCF and its testis-specific paralog BORIS is essential for spermatogenesis. Rivero-Hinojosa S; Pugacheva EM; Kang S; Méndez-Catalá CF; Kovalchuk AL; Strunnikov AV; Loukinov D; Lee JT; Lobanenkov VV Nat Commun; 2021 Jun; 12(1):3846. PubMed ID: 34158481 [TBL] [Abstract][Full Text] [Related]
19. Widespread expression of BORIS/CTCFL in normal and cancer cells. Jones TA; Ogunkolade BW; Szary J; Aarum J; Mumin MA; Patel S; Pieri CA; Sheer D PLoS One; 2011; 6(7):e22399. PubMed ID: 21811597 [TBL] [Abstract][Full Text] [Related]
20. A cell cycle role for the epigenetic factor CTCF-L/BORIS. Rosa-Garrido M; Ceballos L; Alonso-Lecue P; Abraira C; Delgado MD; Gandarillas A PLoS One; 2012; 7(6):e39371. PubMed ID: 22724006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]